Oncology - commissioning policies

Please click on the links below to access the commissioning policies. The associated Equality Impact Assessments, if currently available, are accessible here.

The CCGs’ position on the implementation of policies affecting patient referral can be found here.
Chemoembolisation for pleural mesothelioma Cryotherapy as a salvage treatment option for patients with locally recurrent prostate cancer Degarelix for advanced hormone dependent prostate cancer in patients without spinal metastases High intensity focused ultrasound (HIFU) for prostate cancer Zoledronic acid for treatment of multiple myeloma

Please note:  Some commissioning policies approved by the previous commissioning organisations are yet to be reviewed and updated. There is an on-going programme of work in place to review and update these policies. They will then be published under the appropriate category. 

In the meantime they are still applicable to Northern, Eastern and Western Devon CCG. Former NHS Devon policies can be accessed here

Rate this page